A recent study in Clinical Nutrition study, published July 2017, is providing further evidence of the value of personalized nutrition and nutrigenomics. Researchers studied whether dietary linoleic acid (LA) or α-linolenic acid (ALA) can modulate the expression of genes that influence lipid and anthropometric phenotypes. This meta-analysis of 3069 FrenchRead
Omega-3 fatty acids may play a role in cutting one’s risk of fatal neurodegenerative disease amyotrophic lateral sclerosis (ALS) by one third, a new study suggests from the Harvard School of Public Health in Boston. The research suggests that EFA’s could be part of prevention or integrative therapeutic treatment for ALS. By Kathryn C. Fitzgerald, M.Sc, JAMA Neurology, July 2014.